TA212 Colorectal cancer (metastatic) - bevacizumab: Appendix A decision paper presented to the Institute's Guidance Executive
TA212 Colorectal cancer (metastatic) - bevacizumab: Appendix A decision paper presented to the Institute's Guidance Executive
15 July 2013 (101.62 Kb 29 sec) |
This page was last updated: 11 July 2013